• LAST PRICE
    2.2500
  • TODAY'S CHANGE (%)
    Trending Down-0.0100 (-0.4425%)
  • Bid / Lots
    2.1900/ 1
  • Ask / Lots
    2.3100/ 10
  • Open / Previous Close
    2.2600 / 2.2600
  • Day Range
    Low 2.2500
    High 2.3000
  • 52 Week Range
    Low 1.2700
    High 4.6250
  • Volume
    17,384
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.26
TimeVolumeCHEK
09:32 ET45112.26
09:34 ET10002.3
09:38 ET28392.275
10:06 ET73612.27
10:15 ET15212.25
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCHEK
Check Cap Ltd
13.2M
-0.7x
---
United StatesKPRX
Kiora Pharmaceuticals Inc
13.4M
-0.2x
---
United StatesXTLB
X T L Biopharmaceuticals Ltd
12.9M
-4.8x
---
United StatesMBOT
Microbot Medical Inc
12.8M
-0.8x
---
United StatesNNVC
NanoViricides Inc
13.8M
-1.5x
---
United StatesEDSA
Edesa Biotech Inc
14.0M
-1.7x
---
As of 2024-04-19

Company Information

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

Contact Information

Headquarters
29 Abba Hushi Ave., Isfiya P.O.Box 1271, Israel 3009000
Phone
---
Fax
---

Executives

Chairman of the Board
Steven Hanley
Chief Executive Officer
Alex Ovadia
Chief Financial Officer
Dan Hilerowitz
Chief Technology Officer
Yoav Kimchy
Vice President - Operations
Joshua Belkar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$13.2M
Revenue (TTM)
$0.00
Shares Outstanding
5.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.21
EPS
$-3.01
Book Value
$7.07
P/E Ratio
-0.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.